ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
16.47
-0.02 (-0.12%)
Feb 5, 2026, 11:33 AM EST - Market open
ADMA Biologics Market Cap
ADMA Biologics has a market cap or net worth of $3.92 billion as of February 5, 2026. Its market cap has increased by 3.51% in one year.
Market Cap
3.92B
Enterprise Value
3.95B
1-Year Change
3.51%
Ranking
Category
Stock Price
$16.47
Market Cap Chart
Since October 17, 2013, ADMA Biologics's market cap has increased from $50.20M to $3.92B, an increase of 7,708.41%. That is a compound annual growth rate of 42.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 4.17B | -3.95% |
| Dec 31, 2025 | 4.34B | 7.08% |
| Dec 31, 2024 | 4.05B | 296.92% |
| Dec 29, 2023 | 1.02B | 33.78% |
| Dec 30, 2022 | 763.50M | 176.53% |
| Dec 31, 2021 | 276.10M | 49.73% |
| Dec 31, 2020 | 184.40M | -22.29% |
| Dec 31, 2019 | 237.30M | 114.17% |
| Dec 31, 2018 | 110.80M | -12.41% |
| Dec 29, 2017 | 126.50M | 91.67% |
| Dec 30, 2016 | 66.00M | -23.70% |
| Dec 31, 2015 | 86.50M | -16.67% |
| Dec 31, 2014 | 103.80M | 44.37% |
| Dec 31, 2013 | 71.90M | 43.23% |
| Oct 17, 2013 | 50.20M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apogee Therapeutics | 4.65B |
| Amicus Therapeutics | 4.48B |
| TG Therapeutics | 4.35B |
| Corcept Therapeutics | 4.28B |
| CG Oncology | 4.24B |
| Terns Pharmaceuticals | 4.19B |
| ACADIA Pharmaceuticals | 4.19B |
| Liquidia | 4.06B |